Faculty Opinions recommendation of A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity.
1999 ◽
Vol 63
(4)
◽
pp. 569-580
◽
Keyword(s):
2010 ◽
Vol 53
(10)
◽
pp. 4300-4304
◽
Keyword(s):